SE418966B - Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan - Google Patents

Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan

Info

Publication number
SE418966B
SE418966B SE7402101A SE7402101A SE418966B SE 418966 B SE418966 B SE 418966B SE 7402101 A SE7402101 A SE 7402101A SE 7402101 A SE7402101 A SE 7402101A SE 418966 B SE418966 B SE 418966B
Authority
SE
Sweden
Prior art keywords
compounds
preparation
gastric acid
inhibitory effects
acid secretion
Prior art date
Application number
SE7402101A
Other languages
English (en)
Swedish (sv)
Other versions
SE7402101L (no
Inventor
P B Berntsson
S A I Carlsson
L E Garberg
U K Junggren
S E Sjostrand
Wittken Sundell G W Von
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE7402101A priority Critical patent/SE418966B/xx
Priority to ZA00750558A priority patent/ZA75558B/xx
Priority to DE19752504252 priority patent/DE2504252A1/de
Priority to SU752106386A priority patent/SU795476A3/ru
Priority to CS75987A priority patent/CS194715B2/cs
Priority to CH182975A priority patent/CH616160A5/de
Priority to FI750421A priority patent/FI59590C/fi
Priority to AU78206/75A priority patent/AU499639B2/en
Priority to DD184221A priority patent/DD119422A5/xx
Priority to DK54075AA priority patent/DK141122B/da
Priority to AT113775A priority patent/AT343659B/de
Priority to FR7504888A priority patent/FR2261007B1/fr
Priority to CA220,235A priority patent/CA1060448A/en
Priority to IE307/75A priority patent/IE40858B1/xx
Priority to HU75HE00000679A priority patent/HU172141B/hu
Priority to BE153453A priority patent/BE825655A/xx
Priority to GB6869/75A priority patent/GB1500043A/en
Priority to JP50020284A priority patent/JPS5924157B2/ja
Priority to NL7501917A priority patent/NL7501917A/xx
Priority to NO750541A priority patent/NO142401C/no
Priority to LU71872A priority patent/LU71872A1/xx
Publication of SE7402101L publication Critical patent/SE7402101L/
Priority to US05/655,246 priority patent/US4045564A/en
Priority to HK670/80A priority patent/HK67080A/xx
Priority to SE8101654A priority patent/SE434267B/sv
Publication of SE418966B publication Critical patent/SE418966B/xx
Priority to MY208/81A priority patent/MY8100208A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
SE7402101A 1974-02-18 1974-02-18 Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan SE418966B (sv)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE7402101A SE418966B (sv) 1974-02-18 1974-02-18 Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
ZA00750558A ZA75558B (en) 1974-02-18 1975-01-27 Gastric acid secretion agents
DE19752504252 DE2504252A1 (de) 1974-02-18 1975-02-01 Heterocyclische verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel
SU752106386A SU795476A3 (ru) 1974-02-18 1975-02-14 Способ получени производныхбЕНзиМидАзОлА или иХ СОлЕй
CS75987A CS194715B2 (en) 1974-02-18 1975-02-14 Method of producing new derivatives of 2-/2-heterocyclylmethylthio/benzimidazole
CH182975A CH616160A5 (en) 1974-02-18 1975-02-14 Process for the preparation of novel compounds which affect gastric acid secretion
FI750421A FI59590C (fi) 1974-02-18 1975-02-14 Foerfarande foer framstaellning av terapeutiskt aktiva substituerade bensimidazoler eller syraadditionssalter daerav
AU78206/75A AU499639B2 (en) 1974-02-18 1975-02-14 Pyridyl benzimidazoles
DD184221A DD119422A5 (no) 1974-02-18 1975-02-14
DK54075AA DK141122B (da) 1974-02-18 1975-02-14 Analogifremgangsmåde til fremstilling af substituerede benzimidazoler eller syreadditionssalte deraf.
IE307/75A IE40858B1 (en) 1974-02-18 1975-02-17 New benzimidazole derivatives,their preparation,and their use in affecting gastric acid secretion
FR7504888A FR2261007B1 (no) 1974-02-18 1975-02-17
CA220,235A CA1060448A (en) 1974-02-18 1975-02-17 Gastric acid secretion agents
AT113775A AT343659B (de) 1974-02-18 1975-02-17 Verfahren zur herstellung von neuen benzimidazol-derivaten und deren saureadditionssalzen
HU75HE00000679A HU172141B (hu) 1974-02-18 1975-02-17 Sposob poluchenija proizvodnykh 2-/2-piridil-metil-tio/-benzimidazola
NO750541A NO142401C (no) 1974-02-18 1975-02-18 Analogifremgangsmaate til fremstilling av mavesyresekresjonshemmende 2-pyridylalkyltiobenzimidazoler
GB6869/75A GB1500043A (en) 1974-02-18 1975-02-18 Benzimidazole derivatives their preparation and their use in affecting gastric acid secretion
JP50020284A JPS5924157B2 (ja) 1974-02-18 1975-02-18 新規な化合物の製造法
NL7501917A NL7501917A (nl) 1974-02-18 1975-02-18 Farmaceutisch preparaat en heterocyclische verbinding alsmede werkwijze voor het bereiden daarvan.
BE153453A BE825655A (fr) 1974-02-18 1975-02-18 Perfectionnements apportes aux agents de secretion de l'acide gastrique
LU71872A LU71872A1 (no) 1974-02-18 1975-02-18
US05/655,246 US4045564A (en) 1974-02-18 1976-02-04 Benzimidazole derivatives useful as gastric acid secretion inhibitors
HK670/80A HK67080A (en) 1974-02-18 1980-11-27 New benzimidazole derivatives, their preparation, and their use in affecting gastric acid secretion
SE8101654A SE434267B (sv) 1974-02-18 1981-03-16 Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
MY208/81A MY8100208A (en) 1974-02-18 1981-12-30 New benzimidazole derivatives,their preparation, and their use in affecting gastric acid secretion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7402101A SE418966B (sv) 1974-02-18 1974-02-18 Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan

Publications (2)

Publication Number Publication Date
SE7402101L SE7402101L (no) 1975-08-19
SE418966B true SE418966B (sv) 1981-07-06

Family

ID=20320233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7402101A SE418966B (sv) 1974-02-18 1974-02-18 Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan

Country Status (23)

Country Link
JP (1) JPS5924157B2 (no)
AT (1) AT343659B (no)
AU (1) AU499639B2 (no)
BE (1) BE825655A (no)
CA (1) CA1060448A (no)
CH (1) CH616160A5 (no)
CS (1) CS194715B2 (no)
DD (1) DD119422A5 (no)
DE (1) DE2504252A1 (no)
DK (1) DK141122B (no)
FI (1) FI59590C (no)
FR (1) FR2261007B1 (no)
GB (1) GB1500043A (no)
HK (1) HK67080A (no)
HU (1) HU172141B (no)
IE (1) IE40858B1 (no)
LU (1) LU71872A1 (no)
MY (1) MY8100208A (no)
NL (1) NL7501917A (no)
NO (1) NO142401C (no)
SE (1) SE418966B (no)
SU (1) SU795476A3 (no)
ZA (1) ZA75558B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266326A1 (en) * 1986-10-27 1988-05-04 Aktiebolaget Hässle Novel derivatives of benzimidazoles active as anti-ulcer agents

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
JPS5364103A (en) * 1976-09-24 1978-06-08 Hitachi Ltd Waste heat recovery boiler
IN148930B (no) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3047388A1 (de) * 1980-12-16 1982-07-15 Basf Ag, 6700 Ludwigshafen Isatogenderivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
IL66340A (en) * 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
DE3216843C2 (de) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4552886A (en) * 1982-06-07 1985-11-12 Eli Lilly And Company Fungicidal pyridylmethyl-amines
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US4503139A (en) * 1983-05-09 1985-03-05 Polaroid Corporation Photographic products and processes and novel compounds
US4575554A (en) * 1983-12-05 1986-03-11 The Upjohn Company Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
US4767770A (en) * 1984-06-18 1988-08-30 Eli Lilly And Company Method of inhibiting aromatase
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
WO1989005643A1 (en) * 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
JPH021280U (no) * 1988-06-14 1990-01-08
US5175286A (en) * 1988-09-20 1992-12-29 Hisamitsu Pharmaceutical Co., Inc. Dibenz[b,e]oxepin derivatives
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
JP2679745B2 (ja) * 1989-06-29 1997-11-19 明治製菓株式会社 アゾール誘導体及びそれらを有効成分とする抗潰瘍剤
JPH0347053U (no) * 1989-09-16 1991-04-30
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5049674A (en) 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
AU2003226706A1 (en) * 2002-03-27 2003-10-08 Altana Pharma Ag Novel alkoxypyridine-derivatives
ES2273225T3 (es) * 2003-02-25 2007-05-01 Altana Pharma Ag Derivados de imidazo (4,5-b) quinolina y su uso como inhibidores de la no-sintasa.
EA200600601A1 (ru) * 2003-10-01 2006-10-27 Алтана Фарма Аг Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы
AU2004276014A1 (en) * 2003-10-01 2005-04-07 Altana Pharma Ag Imidazopyridine-derivatives as inducible no-synthase inhibitors
BRPI0414873A (pt) * 2003-10-01 2006-12-12 Altana Pharma Ag derivados de imidazopiridina como inibidores de no-sintase induzìveis
NZ546437A (en) 2003-10-01 2009-09-25 Altana Pharma Ag Imidazopyridine-derivatives as inducible NO-synthase inhibitors
JP2007507463A (ja) 2003-10-01 2007-03-29 アルタナ　ファルマ　アクチエンゲゼルシャフト 誘導性ＮＯシンターゼ阻害剤としてのイミダゾ［４，５−ｂ］ピリジン誘導体
EP2070923A1 (de) 2007-12-11 2009-06-17 Bayer CropScience AG Insektizide Iminoheterocyclen
EP2576540B1 (en) * 2010-05-26 2019-09-04 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (no) * 1968-10-21 1971-06-03

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266326A1 (en) * 1986-10-27 1988-05-04 Aktiebolaget Hässle Novel derivatives of benzimidazoles active as anti-ulcer agents

Also Published As

Publication number Publication date
DD119422A5 (no) 1976-04-20
FR2261007B1 (no) 1978-11-24
CA1060448A (en) 1979-08-14
ATA113775A (de) 1977-10-15
JPS5924157B2 (ja) 1984-06-07
BE825655A (fr) 1975-08-18
FR2261007A1 (no) 1975-09-12
GB1500043A (en) 1978-02-08
CS194715B2 (en) 1979-12-31
NO142401C (no) 1980-08-13
SU795476A3 (ru) 1981-01-07
IE40858B1 (en) 1979-08-29
MY8100208A (en) 1981-12-31
ZA75558B (en) 1976-01-28
AU499639B2 (en) 1979-04-26
AU7820675A (en) 1976-08-19
LU71872A1 (no) 1975-12-09
IE40858L (en) 1975-08-18
NL7501917A (nl) 1975-08-20
DK141122B (da) 1980-01-21
FI59590B (fi) 1981-05-29
DK141122C (no) 1980-07-07
SE7402101L (no) 1975-08-19
HK67080A (en) 1980-12-05
NO142401B (no) 1980-05-05
DE2504252C2 (no) 1989-02-02
NO750541L (no) 1975-08-19
AT343659B (de) 1978-06-12
JPS50116474A (en) 1975-09-11
FI59590C (fi) 1981-09-10
CH616160A5 (en) 1980-03-14
FI750421A (no) 1975-08-19
HU172141B (hu) 1978-06-28
DE2504252A1 (de) 1975-08-21
DK54075A (no) 1975-10-20

Similar Documents

Publication Publication Date Title
SE418966B (sv) Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
NO146200C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 16-oksygenerte prostansyrederivater
SE424637B (sv) Analogiforfarande for framstellning av pyridylguanidiner med terapeutisk verkan
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE7513085L (sv) Forfarande for framstellning av etrar
DK143801C (da) Analogifremgangsmaade til fremstilling af dihydrolysergsyrederivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
NO147917C (no) Fremgangsmaate for fremstilling av 3-metyl-delta3-cefem-4-karboksylsyre-forbindelser
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
NO152509C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cephalosporinforbindelser
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE404926B (sv) Analogiforfarande for framstellning av 3-piperazin-isokinoliner
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7402101-5

Effective date: 19910117

Format of ref document f/p: F